American Addiction Centers
With over 20 years of clinical experience in psychiatry, Dr. Michael Murphy, MD, MPH, is a valuable asset to the West Florida community and American Addiction Centers family. Prior to coming to River Oaks in 2018, Dr. Murphy served as the national medical director for Hospital Corporation of America (HCA) Behavioral Health Services and, over the course of 12 years, held several leadership positions for a number of psychiatric hospitals and medical centers in Tennessee.
Dr. Murphy is a renowned expert in the diagnosis and treatment of major mental illness and substance abuse disorders with extensive experience leading initiatives in patient safety, violence prevention, integrated care, and medical comorbidity. He is a member of the American Psychiatric Association and author of Blueprints in Psychiatry, a textbook for medical students, the sixth edition of which was published in 2018.
Dr. Murphy’s experience includes servicing on the faculty of Harvard Medical School’s Consolidated Department of Psychiatry and as the medical director of the Appleton long-term treatment program at McLean Hospital in Belmont, Massachusetts for 8 years. He is also a member of the American Board of Psychiatry and Neurology, American Society of Addiction Medicine, American College of Healthcare Executives, and National Association of Behavioral Health.
Dr. Murphy’s strong passion for treating trauma, mood disorders, and substance use disorders is exemplified through his clinical care in which he combines sound psychiatric reasoning with a positive relational spirit.
As River Oak’s medical director, Dr. Murphy oversees the clinical team ensures each patient receives the high-quality care that they deserve and that will help set them on the path to long-term recovery.
This person is not in any offices
American Addiction Centers
AAC Holdings, Inc. is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1, 139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers. In addition, the Company focuses on expanding The Oxford Centre facility. As of June 30, 2016, the Company's capacity at its Forterus treatment facility was 14 beds. The Company is engaged in deploying research-based treatment programs with structured curricula for detoxification, residential treatment, partial hospitalization and intensive outpatient care. The Company is also an Internet marketer in the addiction treatment industry.